Section Editors

Murat Emre - Professor, Behavioral Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University

Murat Emre

Professor, Behavioral Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University

Prof. Murat Emre was born in 1956, in Eregli, Turkey. After studying medicine at the Istanbul Faculty of Medicine he was trained in neuroscience and clinical neurology at the University of Zürich. He then worked in the fields of neurorehabilitation and clinical research in Switzerland for several years. He trained in movement disorders with Prof. David Marsden at the Queen Square National Hospital for Nervous Diseases, London and in behavioural neurology with Prof. Marsel Mesulam at the Beth Israel Hospital and Harvard Medical School. In 1996 he was assigned as Professor of Neurology at the İstanbul Faculty of Medicine, Department of Neurology, where he started the Behavioural Neurology and Movement Disorders Unit. His research interests are in Parkinson’s disease and related disorders, in particular cognitive aspects of the disease, Alzheimer’s disease and related dementias. He has authored or co-authored 125 articles and book chapters, and he has been the Editor of several books.

Latest Articles

Latest Videos

Video List based on Category on Node Page

Latest Videos

Prof. Stuart Isaacson, Editorial Board member for US Neurology, catches up with us to talk about his recent study of apomorphine subcutaneous injection to combat delayed onset of morning levodopa dose, in patients with morning akinesia. He also briefly covers the benefits of using DaTscan in patients with suspected parkinsonian syndromes. Speaker disclosures: Honoraria for CME, consultant,...
Fabrizio Stocchi discusses how OFF periods develop during Levodopa therapy and the use of apomorphine therapy to address these OFF periods. FILMED AT THE INTERNATIONAL CONGRESS OF PARKINSON’S DISEASE AND MOVEMENT DISORDERS (IPMDS), JUNE 2016 CAN YOU EXPLAIN HOW OFF PERIODS DEVELOP DURING LEVODOPA THERAPY IN PARKINSON’S DISEASE? 00:11 – When a patient with Parkinson’s disease is...
Olivier Rascol discusses catechol-O-methyltransferase (COMT) inhibitor use in Parkinson’s Disease and the latest clinical findings on opicapone. FILMED AT THE INTERNATIONAL CONGRESS OF PARKINSON’S DISEASE AND MOVEMENT DISORDERS (IPMDS), JUNE 2016 HOW ARE THE CATECHOL-O-METHYLTRANSFERASE (COMT) INHIBITORS USED IN PARKINSON’S DISEASE? 00:12 – COMT inhibitors have been used for a...